EUVIMEDEUVIMED entdecken
BeobachtungsstudieValidierungsstudieOpen Access · CC BY-NC-ND 4.0

Validation of the European Society of Cardiology Ischemic and Bleeding Risk Criteria for Risk Stratification After Endovascular Therapy in Japanese Patients With Lower Extremity Artery Disease

Hirokazu Shimono iD, Daisuke Kanda iD, Akihiro Tokushige, Nobuhiro Ito, Yutaro Nomoto, Hiroyuki Tabata, Kenta Ohmure iD, Takuro Kubozono iD, Mitsuru Ohishi

Catheterization and Cardiovascular Interventions · 2026

DOI: 10.1002/ccd.70714 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Catheterization and Cardiovascular Interventions, 2026. Verfasst von Hirokazu Shimono und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine and Hypertension, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan. Hauptthemen laut MEDLINE: Decision Support Techniques, Endovascular Procedures, Hemorrhage, Ischemia. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The European Society of Cardiology (ESC) guidelines for peripheral artery disease recommend antithrombotic strategies based on high ischemic risk (HIR) and high bleeding risk (HBR) criteria. However, their prognostic value in patients with lower extremity artery disease (LEAD) undergoing endovascular therapy (EVT) remains unclear. Therefore, we aimed to evaluate whether the number of ESC‐HIR and ESC‐HBR criteria met was associated with clinical outcomes in Japanese patients treated with EVT.

Methods

We retrospectively analyzed 333 patients with LEAD who underwent EVT at a single center. ESC‐HIR and ESC‐HBR scores were separately calculated by assigning 1 point to each criterion and were evaluated independently. The primary outcome was major adverse cardiovascular and limb events (MACLE), defined as the composite of cardiovascular death, myocardial infarction, ischemic stroke, acute limb ischemia, and major amputation.

Results

Over a median follow‐up of 1175 days, 93 patients had MACLE. Higher ESC‐HIR and ESC‐HBR scores were associated with increased MACLE incidence (log‐rank p = 0.022 and p < 0.001). In the multivariable analysis, ESC‐HBR remained independently associated with MACLE (hazard ratio [HR], 1.59; 95% confidence interval [CI], 1.21–2.10; p = 0.001), whereas ESC‐HIR showed a trend toward association (HR, 1.23; 95% CI, 0.99–1.52; p = 0.061). Time‐dependent receiver operating characteristic analysis showed modest discrimination for both scores.

Conclusions

ESC‐HIR and ESC‐HBR scores showed limited prognostic performance for MACLE in Japanese patients undergoing EVT for LEAD. Both scores may be useful for risk stratification in Japanese patients; however, these findings require validation in larger studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Decision Support TechniquesEndovascular ProceduresHemorrhageIschemiaLower ExtremityPeripheral Arterial DiseaseAgedAged, 80 and overFemaleHumansMaleMiddle AgedAmputation, SurgicalClinical RelevanceJapanLimb SalvagePredictive Value of TestsReproducibility of ResultsRetrospective StudiesRisk AssessmentRisk FactorsTime FactorsTreatment Outcome

Stichwörter der Autor:innen

European Society of Cardiologyendovascular therapy (EVT)high bleeding riskhigh ischemic risklower extremity artery disease (LEAD)

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine and Hypertension, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.
  • Department of Prevention and Analysis of Cardiovascular Diseases, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.
  • Department of Clinical Pharmacology and Therapeutics, University of the Ryukyus School of Medicine, Okinawa, Japan.

ORCID-Profile: Hirokazu Shimono, Daisuke Kanda, Kenta Ohmure, Takuro Kubozono

Zitieren

APA

Shimono, H., Kanda, D., Tokushige, A., Ito, N., Nomoto, Y., Tabata, H., Ohmure, K., Kubozono, T., & Ohishi, M. (2026). Validation of the European Society of Cardiology Ischemic and Bleeding Risk Criteria for Risk Stratification After Endovascular Therapy in Japanese Patients With Lower Extremity Artery Disease. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.70714

Vancouver

Shimono H, Kanda D, Tokushige A, Ito N, Nomoto Y, Tabata H, et al. Validation of the European Society of Cardiology Ischemic and Bleeding Risk Criteria for Risk Stratification After Endovascular Therapy in Japanese Patients With Lower Extremity Artery Disease. Catheterization and Cardiovascular Interventions. 2026. doi:10.1002/ccd.70714

BibTeX
@article{Shimono2026,
  author = {Shimono, Hirokazu and Kanda, Daisuke and Tokushige, Akihiro and Ito, Nobuhiro and Nomoto, Yutaro and Tabata, Hiroyuki and Ohmure, Kenta and Kubozono, Takuro and Ohishi, Mitsuru},
  title = {Validation of the European Society of Cardiology Ischemic and Bleeding Risk Criteria for Risk Stratification After Endovascular Therapy in Japanese Patients With Lower Extremity Artery Disease},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2026},
  doi = {10.1002/ccd.70714}
}
Kostenlos starten →